nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Eruption—Gefitinib—lung cancer	0.0778	0.0877	CcSEcCtD
Flurandrenolide—Folliculitis—Erlotinib—lung cancer	0.0455	0.0513	CcSEcCtD
Flurandrenolide—Amcinonide—ANXA1—lung cancer	0.0394	0.348	CrCbGaD
Flurandrenolide—Eruption—Gemcitabine—lung cancer	0.0323	0.0364	CcSEcCtD
Flurandrenolide—Secondary infection—Doxorubicin—lung cancer	0.0299	0.0337	CcSEcCtD
Flurandrenolide—Folliculitis—Paclitaxel—lung cancer	0.0265	0.0298	CcSEcCtD
Flurandrenolide—Leukoderma—Methotrexate—lung cancer	0.0239	0.0269	CcSEcCtD
Flurandrenolide—Eruption—Docetaxel—lung cancer	0.0229	0.0258	CcSEcCtD
Flurandrenolide—Leukoderma—Doxorubicin—lung cancer	0.0207	0.0233	CcSEcCtD
Flurandrenolide—Skin discolouration—Etoposide—lung cancer	0.0188	0.0212	CcSEcCtD
Flurandrenolide—Infection—Crizotinib—lung cancer	0.0187	0.021	CcSEcCtD
Flurandrenolide—Skin discolouration—Paclitaxel—lung cancer	0.0184	0.0208	CcSEcCtD
Flurandrenolide—Infection—Pemetrexed—lung cancer	0.0171	0.0192	CcSEcCtD
Flurandrenolide—Infection—Gefitinib—lung cancer	0.017	0.0191	CcSEcCtD
Flurandrenolide—Hydrocortisone—ANXA1—lung cancer	0.0166	0.147	CrCbGaD
Flurandrenolide—Eruption—Methotrexate—lung cancer	0.0165	0.0186	CcSEcCtD
Flurandrenolide—Folliculitis—Methotrexate—lung cancer	0.0162	0.0182	CcSEcCtD
Flurandrenolide—Eruption—Doxorubicin—lung cancer	0.0143	0.0161	CcSEcCtD
Flurandrenolide—Folliculitis—Doxorubicin—lung cancer	0.014	0.0158	CcSEcCtD
Flurandrenolide—Infection—Teniposide—lung cancer	0.0138	0.0156	CcSEcCtD
Flurandrenolide—Hypersensitivity—Pemetrexed—lung cancer	0.0127	0.0143	CcSEcCtD
Flurandrenolide—Hypersensitivity—Gefitinib—lung cancer	0.0126	0.0142	CcSEcCtD
Flurandrenolide—Dexamethasone—ANXA1—lung cancer	0.0124	0.109	CrCbGaD
Flurandrenolide—Pruritus—Pemetrexed—lung cancer	0.0122	0.0137	CcSEcCtD
Flurandrenolide—Pruritus—Gefitinib—lung cancer	0.0121	0.0136	CcSEcCtD
Flurandrenolide—Rash—Crizotinib—lung cancer	0.0118	0.0134	CcSEcCtD
Flurandrenolide—Dermatitis—Crizotinib—lung cancer	0.0118	0.0133	CcSEcCtD
Flurandrenolide—Skin discolouration—Methotrexate—lung cancer	0.0112	0.0127	CcSEcCtD
Flurandrenolide—Rash—Pemetrexed—lung cancer	0.0108	0.0122	CcSEcCtD
Flurandrenolide—Dermatitis—Pemetrexed—lung cancer	0.0108	0.0122	CcSEcCtD
Flurandrenolide—Rash—Gefitinib—lung cancer	0.0108	0.0121	CcSEcCtD
Flurandrenolide—Dermatitis—Gefitinib—lung cancer	0.0108	0.0121	CcSEcCtD
Flurandrenolide—Hypersensitivity—Teniposide—lung cancer	0.0102	0.0116	CcSEcCtD
Flurandrenolide—Infection—Topotecan—lung cancer	0.0102	0.0115	CcSEcCtD
Flurandrenolide—Infection—Erlotinib—lung cancer	0.0101	0.0114	CcSEcCtD
Flurandrenolide—Pruritus—Teniposide—lung cancer	0.00984	0.0111	CcSEcCtD
Flurandrenolide—Skin discolouration—Doxorubicin—lung cancer	0.00974	0.011	CcSEcCtD
Flurandrenolide—Rash—Teniposide—lung cancer	0.00877	0.00989	CcSEcCtD
Flurandrenolide—Dermatitis—Teniposide—lung cancer	0.00876	0.00988	CcSEcCtD
Flurandrenolide—Infection—Vinorelbine—lung cancer	0.00876	0.00988	CcSEcCtD
Flurandrenolide—Dermatitis contact—Doxorubicin—lung cancer	0.00869	0.0098	CcSEcCtD
Flurandrenolide—Hypersensitivity—Vinblastine—lung cancer	0.00782	0.00882	CcSEcCtD
Flurandrenolide—Hypersensitivity—Topotecan—lung cancer	0.0076	0.00856	CcSEcCtD
Flurandrenolide—Pruritus—Topotecan—lung cancer	0.0073	0.00822	CcSEcCtD
Flurandrenolide—Infection—Irinotecan—lung cancer	0.00723	0.00815	CcSEcCtD
Flurandrenolide—Pruritus—Erlotinib—lung cancer	0.00722	0.00814	CcSEcCtD
Flurandrenolide—Infection—Gemcitabine—lung cancer	0.00704	0.00794	CcSEcCtD
Flurandrenolide—Prednisolone—CYP2A6—lung cancer	0.00666	0.0589	CrCbGaD
Flurandrenolide—Infection—Cisplatin—lung cancer	0.00656	0.0074	CcSEcCtD
Flurandrenolide—Rash—Topotecan—lung cancer	0.0065	0.00733	CcSEcCtD
Flurandrenolide—Hypersensitivity—Vinorelbine—lung cancer	0.0065	0.00733	CcSEcCtD
Flurandrenolide—Dermatitis—Topotecan—lung cancer	0.0065	0.00732	CcSEcCtD
Flurandrenolide—Rash—Erlotinib—lung cancer	0.00643	0.00725	CcSEcCtD
Flurandrenolide—Dermatitis—Erlotinib—lung cancer	0.00643	0.00725	CcSEcCtD
Flurandrenolide—Pruritus—Vinorelbine—lung cancer	0.00624	0.00704	CcSEcCtD
Flurandrenolide—Infection—Etoposide—lung cancer	0.00601	0.00678	CcSEcCtD
Flurandrenolide—Infection—Paclitaxel—lung cancer	0.00589	0.00665	CcSEcCtD
Flurandrenolide—Rash—Vinorelbine—lung cancer	0.00556	0.00627	CcSEcCtD
Flurandrenolide—Dermatitis—Vinorelbine—lung cancer	0.00556	0.00626	CcSEcCtD
Flurandrenolide—Hypersensitivity—Irinotecan—lung cancer	0.00536	0.00604	CcSEcCtD
Flurandrenolide—Pruritus—Gemcitabine—lung cancer	0.00501	0.00565	CcSEcCtD
Flurandrenolide—Infection—Docetaxel—lung cancer	0.005	0.00563	CcSEcCtD
Flurandrenolide—Hypersensitivity—Cisplatin—lung cancer	0.00487	0.00549	CcSEcCtD
Flurandrenolide—Drospirenone—PTGS2—lung cancer	0.00471	0.0417	CrCbGaD
Flurandrenolide—Rash—Irinotecan—lung cancer	0.00459	0.00517	CcSEcCtD
Flurandrenolide—Dermatitis—Irinotecan—lung cancer	0.00458	0.00517	CcSEcCtD
Flurandrenolide—Hydrocortisone—ABCG2—lung cancer	0.00455	0.0403	CrCbGaD
Flurandrenolide—Rash—Gemcitabine—lung cancer	0.00447	0.00504	CcSEcCtD
Flurandrenolide—Dermatitis—Gemcitabine—lung cancer	0.00446	0.00503	CcSEcCtD
Flurandrenolide—Hypersensitivity—Etoposide—lung cancer	0.00446	0.00503	CcSEcCtD
Flurandrenolide—Hypersensitivity—Paclitaxel—lung cancer	0.00437	0.00493	CcSEcCtD
Flurandrenolide—Pruritus—Etoposide—lung cancer	0.00428	0.00483	CcSEcCtD
Flurandrenolide—Pruritus—Paclitaxel—lung cancer	0.0042	0.00473	CcSEcCtD
Flurandrenolide—Rash—Cisplatin—lung cancer	0.00416	0.0047	CcSEcCtD
Flurandrenolide—Dermatitis—Cisplatin—lung cancer	0.00416	0.00469	CcSEcCtD
Flurandrenolide—Rash—Etoposide—lung cancer	0.00382	0.0043	CcSEcCtD
Flurandrenolide—Dermatitis—Etoposide—lung cancer	0.00381	0.0043	CcSEcCtD
Flurandrenolide—Dexamethasone—CYP2A6—lung cancer	0.00379	0.0336	CrCbGaD
Flurandrenolide—Rash—Paclitaxel—lung cancer	0.00374	0.00422	CcSEcCtD
Flurandrenolide—Dermatitis—Paclitaxel—lung cancer	0.00374	0.00421	CcSEcCtD
Flurandrenolide—Hypersensitivity—Docetaxel—lung cancer	0.00371	0.00418	CcSEcCtD
Flurandrenolide—Infection—Methotrexate—lung cancer	0.0036	0.00406	CcSEcCtD
Flurandrenolide—Pruritus—Docetaxel—lung cancer	0.00356	0.00401	CcSEcCtD
Flurandrenolide—Methylprednisolone—ABCB1—lung cancer	0.00352	0.0311	CrCbGaD
Flurandrenolide—Dexamethasone—ABCG2—lung cancer	0.00339	0.03	CrCbGaD
Flurandrenolide—Rash—Docetaxel—lung cancer	0.00317	0.00357	CcSEcCtD
Flurandrenolide—Dermatitis—Docetaxel—lung cancer	0.00317	0.00357	CcSEcCtD
Flurandrenolide—Infection—Doxorubicin—lung cancer	0.00312	0.00352	CcSEcCtD
Flurandrenolide—Betamethasone—PTGS2—lung cancer	0.00286	0.0253	CrCbGaD
Flurandrenolide—Dexamethasone—CYP2E1—lung cancer	0.00269	0.0238	CrCbGaD
Flurandrenolide—Hypersensitivity—Methotrexate—lung cancer	0.00267	0.00301	CcSEcCtD
Flurandrenolide—Dexamethasone—CYP1A1—lung cancer	0.00266	0.0235	CrCbGaD
Flurandrenolide—Pruritus—Methotrexate—lung cancer	0.00256	0.00289	CcSEcCtD
Flurandrenolide—Prednisolone—ABCB1—lung cancer	0.00248	0.0219	CrCbGaD
Flurandrenolide—Betamethasone—ABCB1—lung cancer	0.00243	0.0215	CrCbGaD
Flurandrenolide—Hypersensitivity—Doxorubicin—lung cancer	0.00231	0.00261	CcSEcCtD
Flurandrenolide—Rash—Methotrexate—lung cancer	0.00229	0.00258	CcSEcCtD
Flurandrenolide—Dermatitis—Methotrexate—lung cancer	0.00228	0.00257	CcSEcCtD
Flurandrenolide—Pruritus—Doxorubicin—lung cancer	0.00222	0.0025	CcSEcCtD
Flurandrenolide—Rash—Doxorubicin—lung cancer	0.00198	0.00223	CcSEcCtD
Flurandrenolide—Dermatitis—Doxorubicin—lung cancer	0.00198	0.00223	CcSEcCtD
Flurandrenolide—Hydrocortisone—ABCB1—lung cancer	0.0019	0.0168	CrCbGaD
Flurandrenolide—Dexamethasone—PTGS2—lung cancer	0.00166	0.0147	CrCbGaD
Flurandrenolide—Dexamethasone—ABCB1—lung cancer	0.00141	0.0125	CrCbGaD
